RISK FACTORS INFLUENCING RUPTURE IN METHOTREXATE-TREATED ECTOPIC PREGNANCIES: A RETROSPECTIVE STUDY
Kocatepe Tıp Dergisi · 20.07.2026 · 27 (3) · 331-338
DOI: 10.18229/kocatepetip.1625438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kocatepe Tıp Dergisi, online erschienen am 20.07.2026. Verfasst von İsmail Yılmaz und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
OBJECTIVE: This retrospective study aimed to identify clinical and biochemical factors that predict rupture in ectopic pregnancies treated with methotrexate (MTX) and to guide treatment decision-making between medical and surgical approaches.MATERIAL AND METHODS: A total of 284 patients diagnosed with ectopic pregnancy and initially treated with MTX were included. Among them, 50 patients required subsequent surgical intervention due to rupture, while 234 patients were successfully managed with MTX alone. Data were analyzed using IBM SPSS Statistics version 22. Variables assessed included demographic characteristics (age, parity), obstetric and surgical history (abortion, previous ectopic pregnancy, prior abdominal surgeries), gestational age, blood type, presence of intrauterine device (IUD), presenting symptoms, fetal cardiac activity (FCA), size of ectopic mass, Douglas pouch fluid, endometrial thickness, serial beta-hCG levels, and pathology results.RESULTS: Patients who required surgical intervention had significantly larger ectopic mass sizes (p < 0.01), increased endometrial thickness (p < 0.01), higher initial (day 1) and follow-up (days 4-7) beta-hCG levels (p < 0.001), more frequent presence of fetal cardiac activity (p < 0.01), and a greater history of prior ovarian or tubal surgery (p < 0.05) compared to those successfully treated medically. Additionally, abdominal pain was more common in the surgical group (p < 0.01), while vaginal bleeding was less frequent (p < 0.05).CONCLUSIONS: Ectopic mass size, endometrial thickness, elevated beta-hCG levels, presence of fetal cardiac activity, and prior tubal or ovarian surgery are significant predictors of rupture in ectopic pregnancies treated with MTX. These risk factors should be carefully evaluated before initiating medical management to reduce the risk of treatment failure and adverse outcomes.
Förderung
- None
Zitieren
APA
Yılmaz, İ., & Bayık, R. N. (2026). RISK FACTORS INFLUENCING RUPTURE IN METHOTREXATE-TREATED ECTOPIC PREGNANCIES: A RETROSPECTIVE STUDY. Kocatepe Tıp Dergisi, 27(3), 331-338. https://doi.org/10.18229/kocatepetip.1625438
Vancouver
Yılmaz İ, Bayık RN. RISK FACTORS INFLUENCING RUPTURE IN METHOTREXATE-TREATED ECTOPIC PREGNANCIES: A RETROSPECTIVE STUDY. Kocatepe Tıp Dergisi. 2026;27(3):331-338. doi:10.18229/kocatepetip.1625438
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, İsmail and Bayık, Rahime Nida},
title = {RISK FACTORS INFLUENCING RUPTURE IN METHOTREXATE-TREATED ECTOPIC PREGNANCIES: A RETROSPECTIVE STUDY},
journal = {Kocatepe Tıp Dergisi},
year = {2026},
volume = {27},
number = {3},
pages = {331--338},
doi = {10.18229/kocatepetip.1625438}
}
EUVIMED